AUPO912997A0 - Antiviral agents - Google Patents

Antiviral agents

Info

Publication number
AUPO912997A0
AUPO912997A0 AUPO9129A AUPO912997A AUPO912997A0 AU PO912997 A0 AUPO912997 A0 AU PO912997A0 AU PO9129 A AUPO9129 A AU PO9129A AU PO912997 A AUPO912997 A AU PO912997A AU PO912997 A0 AUPO912997 A0 AU PO912997A0
Authority
AU
Australia
Prior art keywords
antiviral agents
antiviral
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPO9129A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organization CSIRO
Original Assignee
Commonwealth Scientific and Industrial Research Organization CSIRO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO
Priority to AUPO9129A priority Critical patent/AUPO912997A0/en
Publication of AUPO912997A0 publication Critical patent/AUPO912997A0/en
Priority to CN98809019A priority patent/CN1269801A/en
Priority to IDW20000441A priority patent/ID26937A/en
Priority to KR1020007002574A priority patent/KR20010023890A/en
Priority to JP2000510734A priority patent/JP2001515900A/en
Priority to NZ502994A priority patent/NZ502994A/en
Priority to EP98942377A priority patent/EP1019404A4/en
Priority to AU90544/98A priority patent/AU740264C/en
Priority to PCT/AU1998/000748 priority patent/WO1999012927A1/en
Priority to CA002302630A priority patent/CA2302630A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/36—Sulfur atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AUPO9129A 1997-09-11 1997-09-11 Antiviral agents Abandoned AUPO912997A0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
AUPO9129A AUPO912997A0 (en) 1997-09-11 1997-09-11 Antiviral agents
CA002302630A CA2302630A1 (en) 1997-09-11 1998-09-11 Purine acyclonucleosides as antiviral agents
JP2000510734A JP2001515900A (en) 1997-09-11 1998-09-11 Antiviral drugs
IDW20000441A ID26937A (en) 1997-09-11 1998-09-11 ANTIVIRUS SUBSTANCES
KR1020007002574A KR20010023890A (en) 1997-09-11 1998-09-11 Purine acyclonucleosides as antiviral agents
CN98809019A CN1269801A (en) 1997-09-11 1998-09-11 Purine acyclonucleosides as antiviral agents
NZ502994A NZ502994A (en) 1997-09-11 1998-09-11 9-[3-Hydroxy-2-hydroxymethyl-prop-1-yl]-purine derivatives useful as antiviral agents
EP98942377A EP1019404A4 (en) 1997-09-11 1998-09-11 Purine acyclonucleosides as antiviral agents
AU90544/98A AU740264C (en) 1997-09-11 1998-09-11 Antiviral agents
PCT/AU1998/000748 WO1999012927A1 (en) 1997-09-11 1998-09-11 Purine acyclonucleosides as antiviral agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO9129A AUPO912997A0 (en) 1997-09-11 1997-09-11 Antiviral agents

Publications (1)

Publication Number Publication Date
AUPO912997A0 true AUPO912997A0 (en) 1997-10-02

Family

ID=3803414

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPO9129A Abandoned AUPO912997A0 (en) 1997-09-11 1997-09-11 Antiviral agents

Country Status (9)

Country Link
EP (1) EP1019404A4 (en)
JP (1) JP2001515900A (en)
KR (1) KR20010023890A (en)
CN (1) CN1269801A (en)
AU (1) AUPO912997A0 (en)
CA (1) CA2302630A1 (en)
ID (1) ID26937A (en)
NZ (1) NZ502994A (en)
WO (1) WO1999012927A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI20022A (en) * 1998-07-29 2000-02-29 Kemijski inštitut Alkyl substituted purine derivatives and their preparation
KR100377138B1 (en) * 1998-11-10 2003-06-12 주식회사 엘지생명과학 Cyclin's Zonkinase Inhibitor with Purine Structure, Methods for Making the Same, and Anticancer Compositions Containing the Same
GB9903762D0 (en) 1999-02-18 1999-04-14 Novartis Ag Organic compounds
EP1267898A4 (en) * 2000-04-07 2006-02-01 Univ Maryland Bile acid containing prodrugs with enhanced bioavailability
EP2336133A1 (en) 2001-10-30 2011-06-22 Conforma Therapeutics Corporation Purine analogs having HSP90-inhibiting activity
CA2488562A1 (en) * 2002-06-27 2004-01-08 F. Hoffmann-La Roche Ag Synthesis of purine derivatives
AU2004232392A1 (en) * 2003-04-21 2004-11-04 Ustav Organicke Chemie A Biochemie Akademie Ved Ceske Republiky (Purin-6-yl) amino acid and production method thereof
BRPI0414533A (en) 2003-09-18 2006-11-07 Conforma Therapeutics Corp compound, pharmaceutical composition, and methods for inhibiting an hsp90 and treating an individual having an hsp90 mediated disorder
EP1869027A4 (en) 2005-03-30 2010-06-23 Conforma Therapeutics Corp Alkynyl pyrrolopyrimidines and related analogs as hsp90-inhibitors
CN102002043B (en) * 2010-11-16 2012-10-24 江苏科技大学 Method for synthesizing 6-methoxy group purine derivative in presence of 4-aminopyridine as catalyst
CN102633767B (en) * 2012-04-09 2013-10-30 武汉工程大学 Preparation method of non-ionic type iodine contrast medium intermediate 2-isopropyl-5-carboxy-1, 3-dioxane
SI3504210T1 (en) * 2016-08-29 2021-08-31 F. Hoffmann-La Roche Ag 7-substituted sulfonimidoylpurinone compounds for the treatment and prophylaxis of virus infection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5216141A (en) * 1988-06-06 1993-06-01 Benner Steven A Oligonucleotide analogs containing sulfur linkages
GB8904855D0 (en) * 1989-03-03 1989-04-12 Beecham Group Plc Pharmaceutical treatment

Also Published As

Publication number Publication date
CN1269801A (en) 2000-10-11
JP2001515900A (en) 2001-09-25
EP1019404A4 (en) 2001-07-04
WO1999012927A1 (en) 1999-03-18
ID26937A (en) 2001-02-22
EP1019404A1 (en) 2000-07-19
CA2302630A1 (en) 1999-03-18
KR20010023890A (en) 2001-03-26
NZ502994A (en) 2001-12-21

Similar Documents

Publication Publication Date Title
AU3289299A (en) Antiviral agents
AU1709299A (en) Mixer-injectors
AUPQ105499A0 (en) Antiviral agents
AU1027499A (en) 32P-polyphosphazene
AUPQ288499A0 (en) Antiviral agents
AU5272198A (en) EMP-charge-eliminator
AUPO912997A0 (en) Antiviral agents
AU6135896A (en) Antiviral agents
AU4117497A (en) Micropolarimeter
PL338454A1 (en) Lixofuranosilbenzimidazoles as antiviral agents
AU9261198A (en) Antiviral agent
AU5678798A (en) Antiviral agents
AU5391798A (en) Thiamacrolides
AU4469997A (en) Heregulin-gamma
AUPO995297A0 (en) Inorganic antiviral compounds
AUPO906597A0 (en) Antiviral agents
AUPO912897A0 (en) Antiviral agents
AU3194197A (en) Stainblocking agent
AU5540298A (en) Rockbolts
AU1899099A (en) Agents
AUPO230896A0 (en) Antiviral agents
AUPN760596A0 (en) Antiviral agents
AUPP254398A0 (en) Antiviral agents
AUPP388198A0 (en) Antiviral agents
AUPP388098A0 (en) Antiviral agents